000 | 01777 a2200505 4500 | ||
---|---|---|---|
005 | 20250516131044.0 | ||
264 | 0 | _c20130913 | |
008 | 201309s 0 0 eng d | ||
022 | _a1097-0142 | ||
024 | 7 |
_a10.1002/cncr.27938 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSinicrope, Frank A | |
245 | 0 | 0 |
_aBody mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. _h[electronic resource] |
260 |
_bCancer _cApr 2013 |
||
300 |
_a1528-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aColonic Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aEurope _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNorth America _xepidemiology |
650 | 0 | 4 |
_aOverweight _xepidemiology |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aThinness _xepidemiology |
700 | 1 | _aFoster, Nathan R | |
700 | 1 | _aYothers, Greg | |
700 | 1 | _aBenson, Al | |
700 | 1 | _aSeitz, Jean Francois | |
700 | 1 | _aLabianca, Roberto | |
700 | 1 | _aGoldberg, Richard M | |
700 | 1 | _aDegramont, Aimery | |
700 | 1 | _aO'Connell, Michael J | |
700 | 1 | _aSargent, Daniel J | |
773 | 0 |
_tCancer _gvol. 119 _gno. 8 _gp. 1528-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.27938 _zAvailable from publisher's website |
999 |
_c22411254 _d22411254 |